Dear all

I hope you had a relaxing summer time.

Do you face troubles in order to be up to date with all the required legislation changes in various countries in the Regulatory Pharma & Life Sciences field AND combine it with your supply chain and tax strategy?

I am happy to inform you that we have recently launched our Pharma & Life Sciences Regulatory Radar, to strive to assist you in that regard.

Please find some key information in a nutshell as following:

  • Digital solution: The Radar is a digital solution that enables you to keep a tailored overview of all regulatory initiatives from the health authorities in different countries, that are of relevance for you.
  • Purpose: The purpose of the Pharma & Life Sciences Radar is to help you find your required cutting edge information in the pharma & life sciences regulatory field by assisting you to collect, document and archive your key regulatory data that have e.g. also an impact on your tax strategy.
  • Access to the tool: Granted.
  • Costs:  Depending on the numbers of countries and kind of legislation chosen / relevant for your company.
  • Further information: Please find more information in the attached flyer.

Next steps:

Happy to organize a respective live demo of the tool via Webex, if you wishes to receive more insights.



Download PwC’s Pharma & Life Sciences Regulatory Radar:

The Guide to VAT for Clinical Trials in Europe aims at:

Dear readers Hope you had a good start into 2019. As you may already gathered through the press the referendum for the Swiss Tax Bill and AHV-Financing (Steuervorlage und AHV-Finanzierung – STAF) has been launched with success. The respective popular vote will take place in spring, i.e. on 19 May 2019. A lot of pharma […]

Dear all, Happy to invite you to have a look to our latest PwC Webinar on precision medicines and the respective hot topics in the VAT field for the US, Europe, Switzerland and Asia.

I am pleased to invite you to our Webinar on Precision Medicine and Accurate Indirect Tax

My recommendation on your next steps: Choose a holistic approach in order to assess and possibly optimise the health of your value chain (tax, legal, regulatory, operational, digital etc.). Use “scientific” out of the box thinking, innovation and an efficient delivery model as the tools to success.

Are you a pharmaceutical company selling drugs outlined in the list of special drugs and therapies (“Spezialitätenliste”) in Switzerland? If yes, you could benefit from the following information in connection with Swiss VAT.

Have you already heard about the new medical drug ordinance in Switzerland – especially about Art. 21?